← Back to Search

Behavioural Intervention

Mindful Walking for Caregiver Stress

N/A
Recruiting
Led By Sumithra Murthy
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-reported insufficient physical activity (defined as participating in moderate physical activity less than 60 min/week) and not engaged in mindfulness training
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, after 12 weeks and at follow up (20weeks)
Awards & highlights

Study Summary

This trial will study how a mindful walking intervention can reduce stress, improve cognitive function, increase physical activity, and boost self-efficacy for South Asian family caregivers.

Who is the study for?
This trial is for older South Asian family caregivers, aged 50 or above, who look after someone with IDD and are not very active physically (less than 60 minutes of moderate activity per week) and don't practice mindfulness. They should feel stressed, score below 24 on the MMSE test for cognitive function, own a smartphone or tablet to use the Fitbit app, and be able to communicate in English.Check my eligibility
What is being tested?
The study tests a 'MindWalk Intervention' combining physical activity through walking with cognitive training via mindfulness over a period of 12 weeks. Participants will be split into two groups: one will follow the mindful walking program while the other won't. The goal is to see if this helps reduce stress and improve both mental function and physical activity levels.See study design
What are the potential side effects?
Since this intervention involves walking and mindfulness exercises, side effects might include typical exercise-related issues like muscle soreness or strain. Mindfulness may sometimes bring up emotional discomfort if it causes participants to confront stressful thoughts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I exercise less than 60 minutes a week and haven't done mindfulness training.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, after 12 weeks and at follow up (20weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after 12 weeks and at follow up (20weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Executive Functioning Using the NIH Toolbox Dimensional Change Card Sort Test
Perceived Stress using the Acceptance and Action Questionnaire-II (AAQ-II)
Visuospatial inhibitory attention Using the NIH Toolbox Flanker Inhibitory Control and Attention Test
Secondary outcome measures
Overall Self-Efficacy using the NIH ToolBox Emotion Battery on Self-Efficacy for Ages 18+
Physical Activity using Accelerometer to measure step counts
Physical Activity using Accelerometer to measure time spent on moderate-to-vigorous physical activity (MVPA)
+3 more

Trial Design

2Treatment groups
Active Control
Group I: MindWalk InterventionActive Control1 Intervention
12 week intervention: 1) a mindful walking training followed by 2) a prescribed mindful walking regimen, 3) self-reporting of adherence to regimen by the participants using activity logbooks and use of a user-friendly PA tracker (Fitbit Charge HR) for daily step count, and 4) personalized text messages with reminders and motivational messages for participants to do the mindful walking as prescribed including a weekly check-in call or text message for accountability.
Group II: Control groupActive Control1 Intervention
For the participants assigned to control group, there is no intervention. At the end of study, the control group participants will be given access to the recorded virtual mindful walking training only (this includes the 30 minutes introductory training and the weekly 10-minute mindfulness topics/modules).

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
614 Previous Clinical Trials
1,562,301 Total Patients Enrolled
3 Trials studying Cognitive Decline
45,582 Patients Enrolled for Cognitive Decline
Sumithra MurthyPrincipal InvestigatorUniversity of Illinois at Chicago
~33 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top